Springworkstx
Founded 2017 Β· 2 known investors
SpringWorks is a biopharmaceutical company developing targeted oncology and rare disease therapies, including its gamma secretase inhibitor nirogacestat being evaluated in BCMA combination regimens for multiple myeloma. It focuses on late-stage rare oncology programs for patients with severe rare diseases and cancers.
BiotechHealthtech
Investors Β· 2
Frequently asked questions
- What does Springworkstx do?
- SpringWorks is a biopharmaceutical company developing targeted oncology and rare disease therapies, including its gamma secretase inhibitor nirogacestat being evaluated in BCMA combination regimens for multiple myeloma. It focuses on late-stage rare oncology programs for patients with severe rare diseases and cancers.
- Who are Springworkstx's investors?
- Springworkstx's investors include Frazier Life Sciences, Pfizer Venture Investments.